Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam toluenesulfonate versus propofol in radical lung cancer surgery
ChiCTR2100050236Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and propofol in bronchial carcinoma (2 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoints: Blood gas analysis, Hemodynamics and 7 more. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on ChiCTR2100050236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050236.